Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Clinical trial NCT07499674 · RECRUITING

Trial details

NCT number: NCT07499674
Sponsor: Vergent Bioscience, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Lung Metastases

Start date: 2026-03-31
Primary completion: 2026-12-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.